Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
Abstract In the era of immunotherapy, there lacks of a reliable genomic predictor to identify optimal patient populations in combined radiotherapy and immunotherapy (CRI). The purpose of this study is to investigate whether genomic scores defining radiosensitivity are associated with immune response...
Main Authors: | Yang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, Cheng-Hsiang Lo, Jen-Fu Yang, Chun-Shu Lin, Hsing-Lung Chao, Wen-Yen Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | npj Genomic Medicine |
Online Access: | https://doi.org/10.1038/s41525-021-00200-0 |
Similar Items
-
Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
by: Luis A. Pérez-Romasanta, et al.
Published: (2021-01-01) -
Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
by: Jen-Fu Yang, et al.
Published: (2019-10-01) -
Application of Radiosensitizers in Cancer Radiotherapy
by: Gong L, et al.
Published: (2021-02-01) -
The Confluence of Radiotherapy & Immunotherapy
by: Ralph Robert Weichselbaum, et al.
Published: (2012-10-01) -
Predicting Factors of Radiosensitivity in Individual Radiotherapy
by: Sh ghasemi, et al.
Published: (2015-10-01)